Biolojic Design Ltd
- Biotech or pharma, therapeutic R&D
Biolojic is a clinically validated AI platform generating a pipeline of smart antibodies.
Biolojic uses its proprietary AI platform to design antibodies with new capabilities including:
- Epitope-specific antibodies (including functional agonists)
- Multibodies - multi-specific symmetrical IgG binding to more than one target on the same Fab.
- Biolojic’s multibodies may solve key challenges in treating autoimmune diseases and cancers
- In oncology, multibodies can possibly be used standalone or as a basis for an ADC, creating a Multibody Drug Conjugate.
Biolojic first AI designed antibody is currently in Phase 2, developed by Biolojic's daughter company Aulos.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}